- World rank, 2022–2025
- #13,149 of 28,054 · #18,711 all time
- Rank in South Korea
- #238 of 417
- Research works
- 169 ▲ 22% vs 2013–17
- Citations
- 4.5k 26.8 per fractional work
- Top-10% rate
- 30.5% record average 16.5%
- Open access
- 56% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.0×. Every wedge is a field page.
- Pharmacology, Toxicology and Pharmaceutics 7.0×
- Immunology and Microbiology 5.3×
- Biochemistry, Genetics and Molecular Biology 4.4×
- Veterinary 3.5×
- Medicine 2.9×
- Nursing 1.4×
- Chemical Engineering 1.1×
- Chemistry 0.8×
- Neuroscience 0.8×
- Mathematics 0.5×
- Economics, Econometrics and Finance 0.5×
- Health Professions 0.4×
- Decision Sciences 0.3×
- Computer Science 0.2×
- Materials Science 0.2×
- Environmental Science 0.1×
- Engineering 0.1×
- Physics and Astronomy 0.1×
- Earth and Planetary Sciences 0.1×
- Dentistry 0.1×
- Agricultural and Biological Sciences 0.1×
- Social Sciences 0.1×
Which keywords describe research at AstraZeneca (South Korea)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Immunotherapy, Chemotherapy, Clinical Trials, Targeted Therapy, Heart Failure, Cardiovascular Disease and Cancer Therapy.
- Gene Therapy
- Chimeric Antigen Receptor
- Breast Cancer
- Treatment Guidelines
- Therapeutic Antibodies
- Insulin Therapy
- Allergic Diseases
- Lymphoma
- Glycosylation
- Tumor Regression
- Asthma
- Monoclonal Antibodies
- Cardiovascular Risk
- Prognostic Factors
- Cancer Therapy
- Treatment
- Oxidative Stress
- Cardiovascular Disease
- Chemotherapy
- Epidemiology
- Inflammation
- Immunotherapy
- Cancer
- Clinical Trials
- Targeted Therapy
- Biomarkers
- Heart Failure
- Cancer Immunotherapy
- Chronic Kidney Disease
- Tumor Microenvironment
- Clinical Guidelines
- Glycemic Control
- Immunology
- Precision Medicine
- Eosinophils
- TGF-ß
- Therapeutic Targets
- Autoantibodies
- CAR T Cells
- Cytokines
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation7▲ 5.0×37 topics
- Epidemiology5▲ 1.81×23 topics
- Immunotherapy4▲ 8.8×14 topics
- Chemotherapy4▲ 8.4×13 topics
- Cancer3▲ 3.6×25 topics
- Cardiovascular Disease3▲ 4.3×16 topics
- Clinical Trials3▲ 7.2×10 topics
- Oxidative Stress3▲ 2.8×25 topics
- Targeted Therapy3▲ 21×5 topics
- Treatment3▲ 3.4×9 topics
- Biomarkers2▲ 5.6×11 topics
- Cancer Therapy2▲ 6.7×11 topics
- Heart Failure2▲ 8.6×10 topics
- Prognostic Factors2▲ 8.0×8 topics
- Cancer Immunotherapy2▲ 20×3 topics
- Cardiovascular Risk2▲ 10×7 topics
- Chronic Kidney Disease2▲ 13×8 topics
- Monoclonal Antibodies2▲ 34×3 topics
- Tumor Microenvironment2▲ 6.7×8 topics
- Asthma2▲ 29×2 topics
- Clinical Guidelines2▲ 9.4×5 topics
- Tumor Regression2▲ 25×2 topics
- Glycemic Control2▲ 16×4 topics
- Glycosylation2▲ 23×3 topics
- Immunology2▲ 24×2 topics
- Lymphoma2▲ 16×2 topics
- Precision Medicine2▲ 5.4×6 topics
- Allergic Diseases2▲ 39×1 topic
- Eosinophils2▲ 39×1 topic
- Insulin Therapy2▲ 20×3 topics
- TGF-ß2▲ 15×4 topics
- Therapeutic Antibodies2▲ 34×2 topics
- Therapeutic Targets2▲ 15×7 topics
- Treatment Guidelines2▲ 10×4 topics
- Autoantibodies1▲ 9.4×3 topics
- Breast Cancer1▲ 9.0×8 topics
- CAR T Cells1▲ 29×1 topic
- Chimeric Antigen Receptor1▲ 29×1 topic
- Cytokines1▲ 7.9×6 topics
- Gene Therapy1▲ 12×4 topics
Which research topics does AstraZeneca (South Korea) publish most on?
By volume in 2022–2025: Asthma and respiratory diseases, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research and Lung Cancer Treatments and Mutations.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Asthma and respiratory diseases Physiology 2 works
- 2 CAR-T cell therapy research Oncology 1 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
- 5 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 1 works
- 6 Rheumatoid Arthritis Research and Therapies Rheumatology 1 works
- 7 Lung Cancer Research Studies Oncology 1 works
- 8 Chronic Kidney Disease and Diabetes Nephrology 1 works
- 9 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 1 works
- 10 Pancreatic function and diabetes Surgery 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has AstraZeneca (South Korea)'s research output changed?
Output in 2018–2022 was 22% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Seoul
- Seoul National University
- Yonsei University
- Korea University
- Sungkyunkwan University
- Hanyang University
- Kyung Hee University
- Chung-Ang University
- Samsung (South Korea)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.